| 0.59 0.059 (11.11%) | 06-17 13:16 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.75 |
1-year : | 0.88 |
| Resists | First : | 0.64 |
Second : | 0.75 |
| Pivot price | 0.57  |
|||
| Supports | First : | 0.54 |
Second : | 0.48 |
| MAs | MA(5) : | 0.55 |
MA(20) : | 0.56 |
| MA(100) : | 0.82 |
MA(250) : | 1.65 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 18 |
D(3) : | 18.2 |
| RSI | RSI(14): 51.1 |
|||
| 52-week | High : | 2.89 | Low : | 0.48 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NXGL ] has closed below upper band by 36.7%. Bollinger Bands are 69.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 51 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.56 - 0.56 | 0.56 - 0.56 |
| Low: | 0.52 - 0.53 | 0.53 - 0.53 |
| Close: | 0.52 - 0.53 | 0.53 - 0.54 |
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
Mon, 15 Jun 2026
NEXGEL (NXGL) CEO sells 3,000 shares, retains 333,692-holding stake - Stock Titan
Tue, 09 Jun 2026
NEXGEL (NXGL) CEO Adam Levy sells 6,000 common shares but keeps large stake - Stock Titan
Tue, 09 Jun 2026
Large potential dilution as NexGel (NASDAQ: NXGL) seeks note conversion, Nevada move and reverse split - Stock Titan
Thu, 04 Jun 2026
NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th - GlobeNewswire
Wed, 03 Jun 2026
NXGL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Wed, 03 Jun 2026
NEXGEL (NXGL) CEO Adam R. Levy sells 2,000 common shares at $0.5859 - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 9 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 14.7 (%) |
| Held by Institutions | 13.5 (%) |
| Shares Short | 107 (K) |
| Shares Short P.Month | 336 (K) |
| EPS | -0.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.55 |
| Profit Margin | -28.6 % |
| Operating Margin | -36.2 % |
| Return on Assets (ttm) | -20.1 % |
| Return on Equity (ttm) | -61.5 % |
| Qtrly Rev. Growth | -5.6 % |
| Gross Profit (p.s.) | 0.47 |
| Sales Per Share | 1.22 |
| EBITDA (p.s.) | -0.34 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -1.47 |
| PEG Ratio | 0 |
| Price to Book value | 1.06 |
| Price to Sales | 0.47 |
| Price to Cash Flow | -3.81 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|